Definium Therapeutics Inc. Common Shares vs Denison Mines Corp Ordinary Shares (Canada) — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.71B), while Denison Mines Corp Ordinary Shares (Canada) trades at $2.43 (market cap $2.33B). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 2× Denison Mines Corp Ordinary Shares (Canada)'s market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Denison Mines Corp Ordinary Shares (Canada) nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Denison Mines Corp Ordinary Shares (Canada) for 0 Days on average.
| DFTX | DNN | |
|---|---|---|
Market Cap | $4.71B | $2.33B |
Volume | 1,966,636 | 20,155,849 |
Sector | Health | Energy |
52-Week High | $48.45 | $4.37 |
52-Week Low | $10.68 | $2.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $2.17B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Denison Mines is a uranium mining, development, and exploration company focused on Canada's Athabasca Basin. Its portfolio includes the Wheeler River project and interests in other uranium projects and processing facilities.
Read more on DNN →